ECRI warns of fast-tracking COVID-19 vaccines
Editor's Note ECRI announced October 21 that its President and CEO, Marcus Schabacker, MD, PhD, will tell the Food & Drug Administration Vaccines and Related Biological Products Advisory Committee on October 22 that a thorough review of 6 months of completed clinical trial data for COVID-19 vaccines is needed to…
Joint Commission issues new Heads-Up Report on challenges presented by COVID-19
Editor's Note The Joint Commission on October 21 issued a new Heads-Up Report on challenges that accredited organizations are facing during the COVID-19 pandemic. Report topics include: Hospital and critical access hospital emergency privileges Ambulatory healthcare competency assessments Behavioral healthcare identification of environmental risks for suicide Laboratory record keeping for…
Impact of COVID-19 on HAIs
Editor's Note To provide flexibility to healthcare workers responding to the COVID-19 crisis, the Centers for Medicare & Medicaid Services (CMS) waived reporting requirements for healthcare associated infections (HAIs) through June 2020. Using the experience of hospitals in New York City and St Louis, Missouri, the authors provide commentary on…
Faulty bronchoscope reprocessing raises risks of infection transmission
Preventing infection transmission has been a chief concern of healthcare leaders and staff striving to protect their patients and themselves from SARS-CoV-2, the virus that causes COVID-19. The virus poses an insidious threat that includes the possibility of bronchoscopy-associated transmission of COVID-19. Long before the pandemic, epidemiologist and researcher Cori…
FDA reissues EUA for N95 respirators manufactured in China
Editor's Note The Food and Drug Administration (FDA) on October 15 announced that it reissued the Emergency Use Authorization (EUA) for certain N95 and other filtering face-piece respirators that are manufactured in China and are not approved by the Centers for Disease Control and Prevention’s National Institute for Occupational Safety…
CDC: 85% of COVID-19 patients report ‘always’ or ‘often’ wearing masks
Editor's Note Recently published data from a study by the Centers for Disease Control and Prevention (CDC) finds that 70.6% of COVID-19-positive patients report “always” wearing a mask, 14.4% report “often” wearing a mask, and 3.9% report “never” wearing a mask (See Table: Reported use of cloth face covering or…
Joint Commission: Lab surveyors to evaluate CMS reporting requirements for COVID-19 testing results
Editor's Note The Joint Commission announced October 14 that, effective October 15, surveyors will evaluate the Centers for Medicare and Medicaid Services (CMS) reporting requirements for COVID-19 testing results in the Laboratory Accreditation Program. Surveyors will review documentation of COVID-19 test result reporting during the Regulatory Review session of an…
Joint Commission issues new Quick Safety on telehealth
Editor's Note The Joint Commission on October 7 issued a new Quick Safety that focuses on the use of telehealth to deliver patient care while preventing exposure to COVID-19. Other benefits of telehealth in the Quick Safety include: promoting social distancing monitoring the progression of home-quarantined COVID-19 patients enabling providers…
CMS halts COVID-19 testing in non-CLIA-certified labs
Editor's Note The Centers for Medicare & Medicaid Services (CMS) on October 9 announced that it is taking action to stop labs that are testing for COVID-19 without proper Clinical Laboratory Improvements Amendments (CLIA) certification. The agency has issued 171 cease-and-desist letters to US facilities that were testing for COVID-19…
CMS threatens to withhold payments from hospitals not reporting COVID-19, flu data
Editor's Note The Centers for Medicare and Medicaid Services (CMS) on October 6 released guidance on how it will implement an interim final rule that requires hospitals and critical access hospitals to report data on COVID-19 and flu patients. CMS says failure to report specified data may lead to termination…
